Lehrstuhl für Haut- und Geschlechtskrankheiten

GRK 2504: LCMV as model for immune intervention by antigen targeting in chronic viral infections (B2) (GRK 2504 B2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028 CD83-basierte Immunmodulation bei Entzündungen der Augenoberfläche am Bespiel des trockenen Auges (B03) (SFB 1607 B03) SFB 1607: Neue immunmodulierende und anti(lymph)angiogene Therapien für altersassoziierte, zur Erblindung führende Augenerkrankungen Jan. 1, 2024 - Jan. 1, 2027 A100: Soluble CD83-induced pro-resolving macrophages strongly improve and accelerate wound healing processes July 1, 2023 - Dec. 31, 2026 ProDia - Protease Aktivität in Plasma-Vesikeln für die prädiktive Diagnostik von Tumorerkrankungen (DE-ProDia Medical Valley-Award) Nov. 1, 2023 - April 30, 2026 E034: How neural stem cells shape their regulatory environment in the adult CNS July 1, 2023 - March 31, 2026 M5-IZFK-D043: Mechanisms controlling functionality and persistence of CD19.CAR T-cells March 16, 2023 - March 15, 2026 J106: Tissue imprinting of skin-derived immune cells in psoriatic arthritis Sept. 1, 2023 - Feb. 28, 2026 A103: Role of secretory IgA molecules in the intestinal retro-transport mechanism and modulation of bacteria July 1, 2023 - Dec. 31, 2025 Förderung von molekularbiologischen Studien am Aderhautmelanom May 1, 2021 - Dec. 31, 2025 E033: Deubiquitinase Otud7b in oligodendrocyte differentiation and CNS myelination July 1, 2023 - Dec. 31, 2025